Coya Therapeutics (COYA) Change in Account Payables (2022 - 2026)

Coya Therapeutics has reported Change in Account Payables for 5 years, with the latest figure at -$154713.0 in Q1 2026.

• Quarterly Change in Account Payables fell 251.86% year-over-year to -$154713.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$783598.0 (down 867.75% YoY) and the FY2025 annual result came in at -$527006.0, down 210.38% from the prior year.
• Change in Account Payables declined to -$154713.0 in Q1 2026 per COYA's latest filing, from -$50580.0 in the prior quarter.
• Over five years, Change in Account Payables peaked at $1.3 million in Q4 2024 and troughed at -$1.5 million in Q3 2024.
• A 5-year average of $55284.2 and a median of $101879.0 in 2025 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2023 and 2024: Change in Account Payables surged 654.03% in 2023, then tumbled 475.92% in 2024.
• Over 5 years, Change in Account Payables stood at $389106.0 in 2022, then increased by 22.52% to $476727.0 in 2023, then surged by 162.5% to $1.3 million in 2024, then slumped by 104.04% to -$50580.0 in 2025, then tumbled by 205.88% to -$154713.0 in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$154713.0, -$50580.0, and $180358.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.